Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis

Molecular Vision

Volumn 11, Issue , 2005, Pages 114-123

  Zinchuk, Olga ^a   Fukushima, Atsuki ^a   Zinchuk, Vadim ^a   Fukata, Kazuyo ^a   Ueno, Hisayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE; MAJOR BASIC PROTEIN; PROTEIN ANTIBODY; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; EOSINOPHIL; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR UPREGULATION;

ANIMALS; CONJUNCTIVA; CONJUNCTIVITIS; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHILIA; EOSINOPHILS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MICROSCOPY, CONFOCAL; MONOKINES; NERVE TISSUE PROTEINS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED BN; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 25444446396     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bonavida B, Mencia-Huerta JM. Platelet-activating factor and the cytokine network in inflammatory processes. Clin Rev Allergy 1994; 12:381-95.
2. McManus LM, Woodard DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: pathobiological implications. Lab Invest 1993; 69:639-50.
3. Rosenbaum JT, Boney RS, Samples JR, Valone FH. Synthesis of platelet activating factor by ocular tissue from inflamed eyes. Arch Ophthalmol 1991; 109:410-3.
4. Nagase T, Ishii S, Kume K, Uozumi N, Izumi T, Ouchi Y, Shimizu T. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J Clin Invest 1999; 104:1071-6.
5. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987; 39:97-145.
6. Meijer F, Ruijter JM, Van Delft JL, Van Haeringen NJ. Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva. Eur J Pharmacol 1995; 284:61-7.
7. Page CP. The contribution of platelet-activating factor to allergen-induced eosinophil infiltration and bronchial hyperresponsiveness. Lipids 1991; 26:1280-2.
8. Simon HU, Tsao PW, Siminovitch KA, Mills GB, Blaser K. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol 1994; 153:364-77.
9. Rubin RM, Rosenbaum JT. A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. Biochem Biophys Res Commun 1988; 154:429-36.
10. Chan CC, McKee K, Tagari P, Chee P, Ford-Hutchinson A. Eosinophil-eicosanoid interactions: inhibition of eosinophil chemotaxis in vivo by a LTD4-receptor antagonist. Eur J Pharmacol 1990; 191:273-80.
11. Sanz MJ, Weg VB, Bolanowski MA, Nourshargh S. IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody. J Immunol 1995; 154:1364-73.
12. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999; 51:213-340.
13. Honda Z, Ishii S, Shimizu T. Platelet-activating factor receptor. J Biochem (Tokyo) 2002; 131:773-9.
14. Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 2000; 80:1669-99.
15. Mori M, Aihara M, Shimizu T. Localization of platelet-activating factor receptor messenger RNA in the rat eye. Invest Ophthalmol Vis Sci 1997; 38:2672-8.
16. Manders EMM, Verbeek FJ, Aten, JA. Measurement of co-localization of objects in dual-color confocal images. J Microsc 1993; 169:375-382.
17. Smallcombe A, McMillan, D. Co-localisation: how is it determined, and how is it analysed with the Bio-Rad Laser Pix image analysis software? Bio-Rad Technical Note 11.
18. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-45.
19. Kawamoto T. Light microscopic autoradiography for study of early changes in the distribution of water-soluble materials. J Histochem Cytochem 1990; 38:1805-14.
20. Wouterlood FG, Van Denderen JC, Blijleven N, Van Minnen J, Hartig W. Two-laser dual-immunofluorescence confocal laser scanning microscopy using Cy2- and Cy5-conjugated secondary antibodies: unequivocal detection of co-localization of neuronal markers. Brain Res Brain Res Protoc 1998; 2:149-59.
21. Pignol B, Henane S, Sorlin B, Rola-Pleszczynski M, Mencia-Huerta JM, Braquet P. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells. J Immunol 1990; 145:980-4.
22. Bless NM, Huber-Lang M, Guo RF, Warner RL, Schmal H, Czermak BJ, Shanley TP, Crouch LD, Lentsch AB, Sarma V, Mulligan MS, Friedl HP, Ward PA. Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol 2000; 164:2650-9.
23. Shanley TP, Warner RL, Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995; 1:40-5.
24. Babu S, Nutman TB. Proinflammatory cytokines dominate the early immune response to filarial parasites. J Immunol 2003; 171:6723-32.
25. Jalonen TO, Pulkkinen K, Ukkonen M, Saarela M, Elovaara I. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. J Neurol 2002; 249:576-83.
26. Mancardi S, Vecile E, Dusetti N, Calvo E, Stanta G, Burrone OR, Dobrina A. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 2003; 108:523-30.
27. Petrescu AD, Payne HR, Boedecker A, Chao H, Hertz R, Bar-Tana J, Schroeder F, Kier AB. Physical and functional interaction of Acyl-CoA-binding protein with hepatocyte nuclear factor-4 alpha. J Biol Chem 2003; 278:51813-24.
28. McIntosh AL, Gallegos AM, Atshaves BP, Storey SM, Kannoju D, Schroeder F. Fluorescence and multiphoton imaging resolve unique structural forms of sterol in membranes of living cells. J Biol Chem 2003; 278:6384-403.
29. Rickman C, Meunier FA, Binz T, Davletov B. High affinity interaction of syntaxin and SNAP-25 on the plasma membrane is abolished by botulinum toxin E. J Biol Chem 2004; 279:644-51.
30. Parmryd I, Adler J, Patel R, Magee AI. Imaging metabolism of phosphatidylinositol 4,5-bisphosphate in T-cell GM1-enriched domains containing Ras proteins. Exp Cell Res 2003; 285:27-38.
31. Zinchuk O, Fukushima A, Hangstefer E. Dynamics of PAF-induced conjunctivitis reveals differential expression of PAF receptor by macrophages and eosinophils in the rat. Cell Tissue Res 2004; 317:265-77.
32. Bonini S, Adriani E, Bonini S, De Petrillo G, Loggi GG, Adabbo A, Pani M, Balsano F. Allergy and asthma: distinguishing the causes from the triggers. An eye model for the study of inflammatory events following allergen challenge. Eur Respir J Suppl 1989; 6:497s-501s.
33. Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol 2001; 25:707-16.
34. Rubin RM, Samples JR, Rosenbaum JT. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist. Arch Ophthalmol 1988; 106:1116-20.
35. Saito N, Chihara J. [Chemokine (RANTES, eotaxin, etc.)]. Nippon Rinsho 2001; 59:1900-5.
36. Moqbel R, Lacy P. Molecular mechanisms in eosinophil activation. Chem Immunol 2000; 78:189-98.
37. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 2001; 97:1920-4.
38. Etienne A, Soulard C, Thonier F, Braquet P. Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat. Possible roles of interleukin 5 and platelet-activating factor. Int Arch Allergy Appl Immunol 1989; 88:216-21.
39. Nakahara Y, Hayashi S, Fukuno Y, Kawashima M, Yatsunami J. Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia. Respiration 2001; 68:389-95.
40. Wang H, Tan X, Chang H, Huang W, Gonzalez-Crussi F, Hsueh W. Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. Immunology 1999; 97:447-54.
41. Verbey NL, Van Delft JL, Van Haeringen NJ, Braquet P. Platelet-activating factor and laser trauma of the iris. Invest Ophthalmol Vis Sci 1989; 30:1101-3.